About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Optical Clearing of the Skin in Conjunction With Laser Treatments

NCT00580736•University of California, Irvine

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Port Wine StainNevus of OtaTattoos+4 more

Interventions

Optical Clearing

Locations

1

United States

Locations (1)

Beckman Laser Institute Medical and Surgical Clinic

Irvine, California, United States

Key Dates

Start Date

March 1, 2004

Primary Completion Date

July 1, 2008

Completion Date

July 1, 2008

Last Updated

October 20, 2022

Related Studies

Not Yet RecruitingPhase 2

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

NCT07436611

Port Wine Stains

French National Cohort of Children With Port Wine Stain

NCT01364857

Port Wine StainKlippel Trenaunay Syndrome+1 more

COMPLETEDPhase 1

A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

NCT00800722

Port Wine Stain

Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies

NCT01333553

PORT WINE STAIN

WITHDRAWNPhase 1

Pilot Study on the Use of the Matrix Radiofrequencyfor Treatment of Port Wine Stain Birthmarks

NCT01166919

Port Wine Stain

Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences

NCT00540371

Port Wine Stain

View all related studies

Sponsors

Lead Sponsor

University of California, Irvine

Collaborators

Beckman Laser Institute University of California Irvine

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 20, 2022Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions